JPWO2020033784A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020033784A5
JPWO2020033784A5 JP2021531468A JP2021531468A JPWO2020033784A5 JP WO2020033784 A5 JPWO2020033784 A5 JP WO2020033784A5 JP 2021531468 A JP2021531468 A JP 2021531468A JP 2021531468 A JP2021531468 A JP 2021531468A JP WO2020033784 A5 JPWO2020033784 A5 JP WO2020033784A5
Authority
JP
Japan
Prior art keywords
methyl
oxo
amino
dimethylamino
dioxohept
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021531468A
Other languages
English (en)
Japanese (ja)
Other versions
JP7433315B2 (ja
JP2021534240A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/045827 external-priority patent/WO2020033784A1/en
Publication of JP2021534240A publication Critical patent/JP2021534240A/ja
Publication of JPWO2020033784A5 publication Critical patent/JPWO2020033784A5/ja
Application granted granted Critical
Publication of JP7433315B2 publication Critical patent/JP7433315B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021531468A 2018-08-10 2019-08-09 トランスグルタミナーゼ2(tg2)阻害剤 Active JP7433315B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862717697P 2018-08-10 2018-08-10
US62/717,697 2018-08-10
US201962845229P 2019-05-08 2019-05-08
US62/845,229 2019-05-08
PCT/US2019/045827 WO2020033784A1 (en) 2018-08-10 2019-08-09 Transglutaminase 2 (tg2) inhibitors

Publications (3)

Publication Number Publication Date
JP2021534240A JP2021534240A (ja) 2021-12-09
JPWO2020033784A5 true JPWO2020033784A5 (ko) 2022-08-18
JP7433315B2 JP7433315B2 (ja) 2024-02-19

Family

ID=69415167

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021531468A Active JP7433315B2 (ja) 2018-08-10 2019-08-09 トランスグルタミナーゼ2(tg2)阻害剤

Country Status (28)

Country Link
US (2) US20210163480A1 (ko)
EP (2) EP3833348B1 (ko)
JP (1) JP7433315B2 (ko)
KR (1) KR20210044248A (ko)
CN (1) CN112789040A (ko)
AU (1) AU2019318543B2 (ko)
BR (1) BR112021002532A2 (ko)
CA (1) CA3109195A1 (ko)
CL (1) CL2021000328A1 (ko)
CO (1) CO2021001472A2 (ko)
CY (1) CY1126147T1 (ko)
DK (1) DK3833348T3 (ko)
ES (1) ES2947438T3 (ko)
FI (1) FI3833348T3 (ko)
HR (1) HRP20230798T1 (ko)
HU (1) HUE062140T2 (ko)
IL (1) IL280719B2 (ko)
LT (1) LT3833348T (ko)
MX (1) MX2021001550A (ko)
PH (1) PH12021500008A1 (ko)
PL (1) PL3833348T3 (ko)
PT (1) PT3833348T (ko)
RS (1) RS64464B1 (ko)
SG (1) SG11202100736PA (ko)
SI (1) SI3833348T1 (ko)
TW (1) TWI825144B (ko)
UY (1) UY38333A (ko)
WO (1) WO2020033784A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11466017B2 (en) 2011-03-10 2022-10-11 Board Of Regents, The University Of Texas System Heterocyclic inhibitors of PTPN11
CN109475531B (zh) 2016-05-31 2021-08-17 得克萨斯州立大学董事会 Ptpn11的杂环抑制剂
MX2020011528A (es) 2018-05-02 2021-02-09 Navire Pharma Inc Inhibidores heterociclicos sustituidos de ptpn11.
EP4356973A3 (en) 2018-08-10 2024-06-26 Navire Pharma, Inc. 6-(4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-(2,3-dichlorophenyl)-2-methylpyrimidin-4(3h)-one derivatives and related compounds as ptpn11 (shp2) inhibitors for treating cancer
TWI825144B (zh) * 2018-08-10 2023-12-11 美商思達利醫藥公司 第二型轉麩醯胺酸酶(tg2)抑制劑
KR20240035404A (ko) * 2021-06-30 2024-03-15 제디라 게엠베하 트랜스글루타미나제 억제제
WO2023090479A1 (ko) * 2021-11-18 2023-05-25 주식회사 엠디바이오팜 신규한 트랜스글루타미나제 2 억제제 및 이의 용도
CN115611760A (zh) * 2022-10-13 2023-01-17 天津药明康德新药开发有限公司 一种适合规模化生产(s)-2-氨基-5-炔基己酸的化学合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
GB9509271D0 (en) 1995-05-05 1995-06-28 Biopharm Res & Dev Ltd Blood clot stabilisation inhibitors
US7579313B2 (en) * 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
DE102006052755A1 (de) * 2006-11-08 2008-05-15 N-Zyme Biotec Gmbh Michaelsysteme als Transglutaminaseinhibitoren
WO2012078519A2 (en) * 2010-12-06 2012-06-14 Numerate, Inc. 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2
US8889716B2 (en) * 2011-05-10 2014-11-18 Chdi Foundation, Inc. Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
ES2765891T3 (es) * 2011-12-21 2020-06-11 Ono Pharmaceutical Co Derivados de piridinona y pirimidinona como inhibidores del factor XIa
EP2687511A1 (de) * 2012-07-17 2014-01-22 Zedira GmbH Pyridinonderivate als Gewebetransglutaminaseinhibitoren
KR101548789B1 (ko) * 2012-12-21 2015-09-01 주식회사 엘지화학 케이블형 이차전지 및 이의 제조 방법
EP3342779A1 (en) 2016-12-27 2018-07-04 Zedira GmbH Inhibitors of transglutaminases
TWI825144B (zh) * 2018-08-10 2023-12-11 美商思達利醫藥公司 第二型轉麩醯胺酸酶(tg2)抑制劑

Similar Documents

Publication Publication Date Title
US11591336B2 (en) Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
AU2017342027B2 (en) Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
JP7129420B6 (ja) Hpk1阻害剤としてのイソキノリン
JP2024038329A (ja) Irak分解剤およびそれらの使用
JP2022538192A (ja) Irak分解剤およびその使用
KR101506044B1 (ko) C―fms 및/또는 c―kit 활성 조절 화합물 및 이들의 용도
JP2021001212A (ja) Btk阻害薬としての一級カルボキサミド類
TW202108141A (zh) Fgfr抑制劑及其使用方法
JP2022531801A (ja) フェニルアミノピリミジンアミドオートファジー阻害剤およびその使用方法
JP2022531932A (ja) ヘテロアリールアミノピリミジンアミドオートファジー阻害剤およびその使用方法
JP2018150358A (ja) Tank結合キナーゼインヒビター化合物
JP2010523576A5 (ko)
RU2017106742A (ru) Комбинированная терапия для лечения парамиксовируса
JP2009529047A5 (ko)
JP2017524702A5 (ko)
JP6695353B2 (ja) Fgfr4阻害剤としてのホルミル化n−複素環式誘導体
JP2016028073A (ja) キナーゼ調節のための化合物および方法、ならびにそれらの適応症
KR102148681B1 (ko) Pi3 키나제 모듈레이터로서의 헤테로방향족 화합물
CN101605540A (zh) 使用mek抑制剂的方法
WO2010016490A1 (ja) イミダゾピリジン-2-オン誘導体
MX2012005284A (es) Compuestos y metodos para la modulacion de cinasas. e indicaciones para ello.
JP2024503300A (ja) Irak分解剤およびそれらの使用
JP2023545545A (ja) 複素環スピロ化合物及び使用方法
CN111868037B (zh) 作为crhr2拮抗剂的稠合环状脲衍生物
TW202116753A (zh) 以噌啉作為hpk1的抑制劑